Optogenetics Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented by Light Equipment (Laser and Light-emitting Diode),By Actuator (Channelrhodopsin, Halorhodopsin, and Archaerhodopsin), By Sensor (Calcium (Aequorin, Cameleon, and Other Calcium Sensors), Chloride (Clomeleon), Membrane-gated (Mermaid), and Other Sensors), By Application (Neuroscience, Behavioral Trac
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationOptogenetics Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented by Light Equipment (Laser and Light-emitting Diode),By Actuator (Channelrhodopsin, Halorhodopsin, and Archaerhodopsin), By Sensor (Calcium (Aequorin, Cameleon, and Other Calcium Sensors), Chloride (Clomeleon), Membrane-gated (Mermaid), and Other Sensors), By Application (Neuroscience, Behavioral Trac
| Forecast Period | 2024-2028 |
| Market Size (2022) | 545.60 million |
| CAGR (2023-2028) | 4.01% |
| Fastest Growing Segment | NeuroScience |
| Largest Market | North America |
Market Overview
Global Optogenetics Market has valued at USD 545.60 million in 2022 and is anticipated to witness an impressive growth in the forecast period with a CAGR of 4.01% through 2028
Optogenetics has revolutionized neuroscience by enabling precise control of neural circuits. The continuous advancement of our understanding of the brain and the need for sophisticated tools to study it has driven the adoption of optogenetic techniques. Ongoing advancements in optogenetic tools, including the development of improved opsins (light-sensitive proteins) and more precise light-delivery systems, have made optogenetics more accessible and user-friendly for researchers.
Key Market Drivers
Technological Innovations
Opsins are light-sensitive proteins used in optogenetics to control cellular activity. Continuous research has led to the development of new and improved opsins with enhanced properties, such as increased sensitivity to light, faster response times, and altered spectral properties. These innovations have allowed for more precise control of neural circuits. Multiplexing in optogenetics involves the simultaneous activation or inhibition of multiple types of opsins in different neurons or neural populations. This technology allows researchers to study complex neural circuits and interactions. Innovations in multiplexing techniques have improved the scalability and versatility of optogenetic experiments. Advanced optical fiber systems and microscopy techniques have been developed to deliver light with high spatial and temporal precision. These innovations enable researchers to target specific brain regions or even individual neurons with greater accuracy. Researchers have developed wireless optogenetic systems that eliminate the need for tethered light sources and allow for more naturalistic experiments in freely moving animals. This technology enhances the study of behaviors and neural circuits in unrestrained conditions. Miniaturization of optogenetic devices and implants has allowed for less invasive experiments in small animals. These devices can be implanted directly into the brain, enabling long-term and chronic studies. Closed loop optogenetic systems incorporate real-time feedback from neural activity to adjust light stimulation. These systems enable dynamic experiments in response to specific neural patterns, enhancing the understanding of neural circuitry. Innovations in viral vectors and gene delivery techniques have improved the efficiency and specificity of introducing optogenetic tools into target cells or tissues. This has facilitated the adoption of optogenetics in a wider range of organisms and cell types.
Two-photon microscopy combined with optogenetics allows for deeper penetration of light into brain tissue. This innovation has expanded the spatial reach of optogenetic experiments, making it possible to target neurons in deeper brain regions. The development of inhibitory optogenetic tools, such as Halorhodopsin (eNpHR) and Arch, has allowed for the precise inhibition of neural activity. Researchers can now manipulate neural circuits bidirectionally, activating, and inhibiting neurons as needed. In addition to opsins for control, optogenetic sensors have been developed to monitor neural activity and physiological parameters in real-time. These sensors provide valuable feedback for closed-loop experiments and enable the study of neural dynamics. Optogenetics has been integrated with electrophysiological techniques, allowing researchers to combine light stimulation with the recording of neural activity. This integration provides a comprehensive view of neural circuit function. Commercial suppliers have played a significant role in advancing optogenetics by providing researchers with well-characterized and validated optogenetic tools, making them more accessible to a broader scientific community. This factor will help in the development of
Advancements in Neuroscience Research
Neuroscience research has seen significant advancements in recent years, driven by technological innovations, collaborative efforts, and increased funding. These advancements have deepened our understanding of the brain and its functions.
Machine learning and artificial intelligence have been applied to analyze large-scale neural data, making it possible to decode brain activity patterns, predict behavior, and diagnose neurological conditions. Brain-Computer Interfaces (BCIs) have advanced, allowing for more precise control of external devices using brain signals. These interfaces have potential applications in assistive technology and neurorehabilitation. The development of brain organoids, miniaturized 3D brain tissue models derived from stem cells, has enabled researchers to study early brain development, model diseases, and test drug responses in a more realistic environment. Growing understanding of neuroinflammation's role in neurological diseases, such as Alzheimer's and multiple sclerosis, has led to the development of novel therapeutic strategies targeting inflammation. Initiatives like the Human Connectome Project and the BRAIN Initiative (Brain Research through Advancing Innovative Neurotechnologies) have brought together researchers from various disciplines to accelerate our understanding of the brain's structure and function. The field has made strides in addressing ethical considerations related to brain research, including discussions about the responsible use of technologies like optogenetics and brain-computer interfaces. This factor will pace up the demand of Global Optogenetics Market.
Expanding Application Areas
Expanding application areas have indeed been a significant driver for the demand of optogenetics. Originally developed as a powerful research tool for neuroscience, optogenetics has found applications in various fields, expanding its reach and impact. Optogenetics' primary application has been in neuroscience, where it has enabled researchers to control and manipulate specific neurons and neural circuits with unprecedented precision. It has deepened our understanding of brain function, behavior, and the underlying mechanisms of neurological disorders. Optogenetics has been applied in cardiology to control cardiac tissue and study the heart's electrical activity. It has potential applications in arrhythmia research and the development of novel therapies for heart conditions. In optometry, optogenetics has been used to study the visual system and retinal function. Researchers have explored its potential for restoring vision in conditions like retinal degeneration. Optogenetics plays a role in regenerative medicine by allowing researchers to control the differentiation and function of stem cells. It has potential applications in tissue engineering and the development of cell-based therapies. Optogenetics has been used to study pain perception and pathways in the nervous system. Researchers can manipulate pain-related neurons to better understand chronic pain conditions and develop potential interventions. The application of optogenetics in psychiatry research has shed light on the neural circuits involved in mood disorders, addiction, and anxiety. It offers insights into potential targets for therapeutic interventions.
Optogenetics has been used to study hormonal regulation and endocrine systems. Researchers can control the release of hormones and investigate their effects on various physiological processes. Optogenetics has found applications in cancer research, where it has been used to control cell behavior and study tumor growth and metastasis. It offers a tool for manipulating cancer cells and studying their responses. Researchers have applied optogenetics to investigate immune cell behavior and responses. It provides a means to control immune cell activation and study immune system dynamics. Optogenetics is used in bioengineering and synthetic biology to design and control cellular processes. It allows for the precise engineering of cells to perform desired functions. Pharmaceutical and biotechnology companies use optogenetics in drug discovery to screen and test potential drug candidates. It provides a valuable tool for studying cellular responses to drugs. As optogenetics expands into new application areas, discussions around the ethical implications of manipulating neural circuits and cellular functions have become more prominent. This factor will accelerate the demand of
Key Market Challenges
Limited Understanding of Neural Circuits
The human brain is incredibly complex, with billions of neurons and trillions of synapses. Our understanding of how all these elements work together to produce behaviors and cognitive functions is still incomplete. This complexity makes it challenging to design optogenetic experiments that target the right neurons and circuits. Although significant progress has been made in mapping neural circuits, especially in model organisms like mice, there are still gaps in our knowledge. Comprehensive maps of all the neural circuits in the brain are lacking, which can limit the precision of optogenetic experiments. Neural circuits can vary significantly from one individual to another. What works in one person's brain may not work the same way in another person's brain. This variability can complicate the application of optogenetic techniques in clinical settings. Some deep brain regions are challenging to access and study, making it difficult to understand their circuitry. Optogenetic experiments in these regions may be limited by the ability to deliver light to the target neurons effectively. Linking specific neural circuits to complex behaviors and cognitive functions can be a formidable challenge. While optogenetics can manipulate neural activity, understanding the precise relationship between neural activity patterns and behavior is an ongoing endeavor.
Cost of Technology
Optogenetics experiments require specialized equipment, including light sources (e.g., lasers or LEDs), optical fibers, and imaging systems. These components can be expensive, especially for high-quality, research-grade systems. Researchers often need to customize their optogenetic setups to suit their specific experimental needs. Customization can add to the overall cost, as it may require engineering expertise and bespoke components. The purchase of optogenetic reagents, such as viral vectors carrying opsins, is an ongoing expense. These reagents need to be regularly replenished for experiments. In animal studies, maintaining transgenic animals or administering viral vectors can incur costs related to animal housing, care, and ethical oversight. Skilled personnel are needed to conduct optogenetics experiments, from designing protocols to carrying out experiments and data analysis. Employing trained researchers adds to the overall cost. Researchers require training and expertise in optogenetics techniques, which can involve additional costs for workshops, courses, or hiring experts. Consumables such as optical fibers, cannulas, and electrodes need to be regularly replaced, adding to ongoing operational costs.
Key Market Trends
Customization and Targeted Approaches
Researchers are customizing optogenetic tools to suit their experimental requirements. This customization includes the development of novel opsins, such as variants with altered kinetics, spectral properties, or tissue-specific expression patterns. These tailored tools enable more precise and effective control of neural circuits. Multiplexing in optogenetics involves the simultaneous use of multiple opsins with different properties in a single experiment. This approach allows researchers to target distinct neural populations within the same tissue or brain region. Customizing multiplexed optogenetic systems enhances the flexibility of experiments. Customization extends to achieving cell-type specificity in optogenetic experiments. Researchers are designing opsins that selectively target specific cell types, such as excitatory or inhibitory neurons, or neurons expressing specific molecular markers. Optogenetics is increasingly being used for circuit-specific manipulation. Custom-designed opsins and targeting strategies allow researchers to activate or inhibit specific neural pathways or synapses, dissecting complex circuits to understand their function. In the context of potential clinical applications, researchers are developing customized optogenetic approaches to target specific neural circuits associated with neurological and psychiatric disorders. This targeted customization is crucial for the development of precise therapeutic interventions.
Segmental Insights
Light Equipment Insights
In 2022, the Global Optogenetics Market largest share was dominated by Light-emitting Diode (LED) segment in the forecast period and is predicted to continue expanding over the coming years.
Actuator Insights
In 2022, the Global Optogenetics Market dominated by Channel rhodopsin segment and is predicted to continue expanding over the coming years.
Sensor Insights
In 2022, the Global Optogenetics Market dominated by Chloride segment and is predicted to continue expanding over the coming years.
Application Insights
In 2022, the Global Optogenetics Market largest share was dominated by Neuroscience segment in the forecast period and is predicted to continue expanding over the coming years.
Regional Insights
The North America region dominates the Global Optogenetics Market in 2022. Due to the rising prevalence of chronic diseases in the area, the increasing use of optogenetic devices, particularly in university and research labs, and the partnerships and new product launches by important market participants. The main drivers of growth in the neurological field are rising government initiatives. With more investment, more businesses can enter the market and offer creative solutions to meet patient requirements. More care is needed for the growing patient population, which raises the need for optogenetics and accelerates the market's expansion. Additionally, it is projected that partnerships and agreements will propel the industry.
Recent Developments
- In June 2022, The NeuraLight 3D Ultra module was launched by Bruker Corporation tofacilitate cutting-edge neuroscience and optogenetics research applications onBruker's Ultima multiphoton microscopes. NeuraLight 3D Ultra offerscutting-edge 3D holographic photostimulation that is tailored for in-depthfunctional research on neural networks and brain computation. The NeuraLight 3DUltra module uses a new, larger liquid crystal device that opens access to abroader field of vision, increased aiming precision, and a market-leading speedof 600 hologram frames per second, building on Bruker's unique spatial lightmodulator (SLM) technology. Researchers may examine themechanisms behind behaviour, perception, and disease at a greater scale andover a longer period when combined with the imaging capabilities of the Ultima2Pplus microscope.
- In February 2023, The PIONEER Phase I/II clinical trial evaluating GS030for the treatment of retinitis pigmentosa (RP) in 9 patients, with a follow-upup to 4 years (n=1), reported favourable safety data and encouraging efficacysignals at 1-year post-gene therapy administration. GenSight Biologics is abiopharma company focused on developing and commercialising novel genetherapies for retinal neurodegenerative diseases and central nervous systemdisorders. GS030, anoptogenetic therapeutic candidate combining an AAV2-based gene therapy(GS030-DP) with the use of light-stimulating goggles (GS030-MD), is beingtested in the first-in-human, multi-centre, open-label, dose escalation clinicaltrial called PIONEER.
Key Market Players
- Hubner Group (Cobolt Inc.)
- Coherent Inc.
- Gensight Biologics S.A.
- Laserglow Technologies
- Noldus Information Technology Inc.
- Judges’ Scientific PLC (Scientifica)
- Shanghai Laser & Optics Century Co. Ltd
- Bruker Corporation
- Thorlabs Inc
| By Light Equipment | By Actuator | By Sensor | By Application | By Region |
| Laser Light-emitting Diode | Channelrhodopsin Halorhodopsin Archaerhodopsin | Calcium Chloride Membrane-gated Other Sensors | Neuroscience Behavioral Tracking Retinal Disease Treatment Other Applications | North America Asia-Pacific Europe South America Middle East & Africa |
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy